Movement Alert|Rollins Falls 6.8% in Regular Trading, Piper Sandler Downgrades Rating and Slashes Price Target by 28%

Market Focus
Sep 25

On September 25, Rollins fell 6.8% in regular trading, trading at $30.255/share, with turnover of approximately $155 million. The sharp decline was triggered by Piper Sandler downgrading Rollins from Overweight to Neutral and cutting its price target from $46 to $33, representing a reduction of nearly 28%.

The downgrade marks the latest in a string of bearish analyst actions. Argus, RBC, and Bernstein had previously lowered their ratings following a disappointing Q2 report, in which adjusted EPS of $0.32 missed the consensus estimate of $0.34 and revenue of $1.079 billion fell short of the expected $1.092 billion. Organic growth has now underperformed the company's mid-term guidance for three consecutive quarters, while softer residential digital lead volumes and weaker consumer-initiated demand channels have clouded the recovery outlook. The consensus analyst rating has since dropped to Hold, with the average price target declining to $44.44.

Rollins provides pest and wildlife control services to residential and commercial customers in the U.S. and internationally, operating through subsidiaries including Orkin. The company, founded in 1901 and headquartered in Atlanta, Georgia, also experienced a CFO transition earlier this year.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10